These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 10952123)
21. [Current approaches in the medical treatment of advanced ovarian carcinoma]. Aitini E; Cavazzini G; Cantore M; Rabbi C; Pari F; Mambrini A; Malavasi V; Smerieri F Recenti Prog Med; 1994 Dec; 85(12):587-90. PubMed ID: 7899684 [TBL] [Abstract][Full Text] [Related]
22. Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack? Foster BJ; Clagett-Carr K; Marsoni S; Simon R; Leyland-Jones B Cancer Treat Rep; 1986 Aug; 70(8):1003-14. PubMed ID: 3089597 [TBL] [Abstract][Full Text] [Related]
23. The changing landscape of therapeutic strategies for recurrent ovarian cancer. Baumann KH; Wagner U; du Bois A Future Oncol; 2012 Sep; 8(9):1135-47. PubMed ID: 23030488 [TBL] [Abstract][Full Text] [Related]
28. First-line treatment regimens and the role of consolidation therapy in advanced ovarian cancer. Stuart GC Gynecol Oncol; 2003 Sep; 90(3 Pt 2):S8-15. PubMed ID: 13129490 [TBL] [Abstract][Full Text] [Related]
29. Treatment advances in ovarian cancer. Almadrones LA Cancer Nurs; 2003 Dec; 26(6 Suppl):16S-20S. PubMed ID: 15025408 [TBL] [Abstract][Full Text] [Related]
30. New strategies in ovarian cancer: translating the molecular complexity of ovarian cancer into treatment advances. Liu J; Matulonis UA Clin Cancer Res; 2014 Oct; 20(20):5150-6. PubMed ID: 25320365 [TBL] [Abstract][Full Text] [Related]
31. Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. Ledermann JA; Raja FA Eur J Cancer; 2011 Sep; 47 Suppl 3():S104-15. PubMed ID: 21943964 [TBL] [Abstract][Full Text] [Related]
32. Second-line and subsequent therapy for ovarian carcinoma. Peethambaram PP; Long HJ Curr Oncol Rep; 2002 Mar; 4(2):159-64. PubMed ID: 11822988 [TBL] [Abstract][Full Text] [Related]
33. Role of antibodies in diagnosis and treatment of ovarian cancer: Basic approach and clinical status. Bhatt P; Vhora I; Patil S; Amrutiya J; Bhattacharya C; Misra A; Mashru R J Control Release; 2016 Mar; 226():148-67. PubMed ID: 26860284 [TBL] [Abstract][Full Text] [Related]
34. Future directions for the management of ovarian cancer. Kaye SB Eur J Cancer; 2001 Dec; 37 Suppl 9():S19-23. PubMed ID: 11741770 [TBL] [Abstract][Full Text] [Related]
35. Remarks and conclusions on ovarian cancer treatment. Poveda A Int J Gynecol Cancer; 2001; 11 Suppl 1():77-81. PubMed ID: 11489009 [TBL] [Abstract][Full Text] [Related]
36. Advances in Therapy for Advanced Breast Cancer. Vahdat LT Medscape Womens Health; 1996 Oct; 1(10):5. PubMed ID: 9746649 [TBL] [Abstract][Full Text] [Related]
37. The Role of CA-125 in the Management of Ovarian Cancer. Markman M Oncologist; 1997; 2(1):6-9. PubMed ID: 10388024 [TBL] [Abstract][Full Text] [Related]
38. Evaluating the role of IL-12 based therapies in ovarian cancer: a review of the literature. Whitworth JM; Alvarez RD Expert Opin Biol Ther; 2011 Jun; 11(6):751-62. PubMed ID: 21391898 [TBL] [Abstract][Full Text] [Related]
39. [DACOVA. A multicenter study of ovarian cancer]. Bertelsen K Ugeskr Laeger; 1985 Jan; 147(2):77-80. PubMed ID: 3881867 [No Abstract] [Full Text] [Related]